Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment BusinessWire
Market data is delayed by at least 15 minutes.
    Latest Story Top Stories on JNJ
    Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    4:30p ET May 8 '24 BusinessWire

    Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine and John Reed, Executive Vice President, Innovative Medicine R&D will represent the Company in a session scheduled at 2:00 pm (Eastern Time).

    This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

    The audio webcast replay will be available approximately 48-hrs after the webcast.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240508472086/en/

    SOURCE: Johnson & Johnson

    <img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240508472086r1&sid=cmtx6&distro=nx&lang=en" style="width:0;height:0" />

    Media contact: 
    media-relations@its.jnj.com
    
    
    Investor contact: 
    investor-relations@its.jnj.com
    

    COMTEX_452081329/1006/2024-05-08T16:30:13

    Kenvue Announces Pricing of Secondary Offering
    7:13p ET May 14 '24 BusinessWire
    Kenvue Announces Launch of Secondary Offering
    6:46a ET May 13 '24 BusinessWire
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:16p ET May 9 '24 PR Newswire Europe
    Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expe...
    12:15p ET May 9 '24 PR Newswire
    Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Glo...
    4:30p ET May 8 '24 BusinessWire
    Shockwave Medical Reports First Quarter 2024 Financial Results
    4:05p ET May 6 '24 GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    12:22p ET May 6 '24 GlobeNewswire
    Johnson & Johnson to Participate in the 2024 RBC Capital Markets Glob...
    6:06p ET April 8 '24 BusinessWire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Follow...
    12:48p ET April 8 '24 GlobeNewswire
    CARVYKTI(R) is the First and Only BCMA-Targeted Treatment Approved by...
    11:22p ET April 5 '24 PR Newswire

    Market data provided by News provided by